The moral imperative to continue gene editing research on human embryos

Protein and Cell

Volumn 6, Issue 7, 2015, Pages 476-479

  Savulescu, Julian ^a,b   Pugh, Jonathan ^a   Douglas, Thomas ^a   Gyngell, Christopher ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CONGENITAL MALFORMATION; CRISPR CAS SYSTEM; CYSTIC FIBROSIS; EMBRYONIC STEM CELL; FERTILIZATION IN VITRO; GENE EDITING; GENETIC DISORDER; GENETIC ENGINEERING; GENETIC SELECTION; HUMAN; HUMAN EMBRYO; PREGNANCY TERMINATION; PRIORITY JOURNAL; THALASSEMIA; ZYGOTE; AGING; EMBRYO RESEARCH; ETHICS; GENETICS; IN VITRO FERTILIZATION; MAMMALIAN EMBRYO; METABOLISM; MORALITY; PREIMPLANTATION GENETIC DIAGNOSIS; RNA EDITING;

AGING; EMBRYO RESEARCH; EMBRYO, MAMMALIAN; FERTILIZATION IN VITRO; HUMANS; MORALS; PREIMPLANTATION DIAGNOSIS; RNA EDITING; ZYGOTE;

EID: 84943349053     PISSN: 1674800X     EISSN: 16748018     Source Type: Journal    
DOI: 10.1007/s13238-015-0184-y     Document Type: Article

References (19)

1. Annas GJ, Caplan A, Elias S (1996) The politics of human-embryo research—avoiding ethical gridlock. New Engl J Med 334 (20):1329–1332. doi:10.1056/NEJM199605163342012
2. Baltimore BD, Berg P, Botchan M, Carroll D, Charo RA, Church G, Corn JE et al (2015) Biotechnology. A prudent path forward for genomic engineering and germline gene modification. Science 348:36–38
3. Bartke A, Brown-Borg H, Mattison J, Kinney B, Hauck S, Wright C et al (2001) Prolonged longevity of hypopituitary dwarf mice. Exp Gerontol 36:21–28
4. Bourne H, Douglas T, Savulescu J (2012) Procreative beneficence and in vitro gametogenesis. Monash Bioeth Rev 30:29–48
5. Christianson AL, Howson CP, Modell B (2006) March of dimes global report on birth defects. The March of Dimes Birth Defects Foundation, White Plains
6. Devolder K (2005) Creating and sacrificing embryos for stem cells. J Med Ethics 31(6):366–370. doi:10.1136/jme.2004.008599
7. Devolder K (2013) Killing discarded embryos and the nothing-is-lost principle. J Appl Philos 30(4):289–303. doi:10.1111/japp.12033
8. Devolder K, Savulescu J (2005) The moral imperative to conduct embryonic stem cell and cloning research. Camb Q Healthc Ethics 15(1):7–21
9. FitzPatrick W (2003) Surplus embryos, nonreproductive cloning, and the intend/foresee distinction. Hastings Center Rep 33(3):29–36
10. Iyer V, Shen B, Zhang W, Hodgkins A, Keane T, Huang X, Skarnes WC (2015) Off-target mutations are rare in Cas9-modified mice. Nat Methods 12(6):479
11. Lanphier E, Urnov F, Haecker SE, Werner M, Smolenski J (2015) Don’t edit the human germ line. Nature 519:410–411
12. Liang P, Xu Y, Zhang X, Ding C, Huang R, Zhang Z, Lv Jie et al (2015) CRISPR/Cas9-mediated gene editing in human tripronuclear zygotes. Protein Cell 6(5):363–372
13. Munné S, Cohen J (1998) Chromosome abnormalities in human embryos. Human Reproduction Update 4(6):842–855
14. National Health and Medical Research Council (2007) NHMRC ethical guidelines on the use of assisted reproductive technology in clinical practice and research 39. http://www.nhmrc.gov.au/_files_nhmrc/publications/attachments/e78.pdf. Accessed 27 May 2015
15. Outka GH (2002) The ethics of human stem cell research. Kennedy Inst Ethics J 12(2):175–213. doi:10.1353/ken.2002.0012
16. President’s Council on Bioethics (2002) Human cloning and human dignity: the report of the President’s Council on bioethics. PublicAffairs Reports, 1st edn. PublicAffairs, New York
17. Savulescu J (1999) Should we clone human beings? Cloning as a source of tissue for transplantation. J Med Ethics 25(2):87–95
18. Singer P (1993) Practical ethics, 2nd edn. Cambridge University Press, Cambridge (pp 208–209; 226–228)
19. The Human Fertilisation and Embryology Authority (2008) Human Fertilisation and Embryology Act 2008. http://www.legislation.gov.uk/ukpga/2008/22/pdfs/ukpga_20080022_en.pdf. Accessed 27 May 2015